A research team from the Department of Pathology at the University of Hong Kong’s LKS Faculty of Medicine (HKUMed) has discovered that atorvastatin, a widely used cholesterol-lowering drug, could become a powerful new weapon in the fight against liver cancer.
This article was originally published on MedicalXpress.com